These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 35933886

  • 1. The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis.
    Hondelink LM, Schrader AMR, Asri Aghmuni G, Solleveld-Westerink N, Cleton-Jansen AM, van Egmond D, Boot A, Ouahoud S, Khalifa MN, Wai Lam S, Morreau H, Bovee JVMG, van Wezel T, Cohen D.
    Eur J Cancer; 2022 Sep; 173():229-237. PubMed ID: 35933886
    [Abstract] [Full Text] [Related]

  • 2. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
    Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Pathology; 2022 Feb; 54(1):55-62. PubMed ID: 34518039
    [Abstract] [Full Text] [Related]

  • 3. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing.
    Koehne de González A, Mansukhani MM, Fernandes H, Hsiao SJ.
    Cancer Genet; 2022 Apr; 262-263():47-52. PubMed ID: 35007853
    [Abstract] [Full Text] [Related]

  • 4. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.
    Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Pan-TRK Antibody is a Sensitive and Specific Tool for the Detection of NTRK Fusion Genes.
    Bautista-Wong C, Mojica-González Z, Hop-Garcia K, Bornstein Quevedo L.
    Appl Immunohistochem Mol Morphol; 2023 Apr 01; 31(4):213-216. PubMed ID: 37017998
    [Abstract] [Full Text] [Related]

  • 10. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR.
    Am J Surg Pathol; 2018 Jun 01; 42(6):791-798. PubMed ID: 29553955
    [Abstract] [Full Text] [Related]

  • 11. The Use of Pan-Tropomyosin Receptor Kinase Immunohistochemistry as a Screening Tool for the Detection of Neurotrophic Tropomyosin-Related Kinase Fusions: Real-World Data from a National Multicentric Retrospective Study.
    Van Bockstal MR, Beniuga G, Craciun L, Creytens D, Dedeurwaerdere F, Delvenne P, Demetter P, De Wiest B, Dewinne K, Habran L, Pauwels P, Theate I, Vander Borght S, Van Der Steen K, Weynand B.
    Pathobiology; 2022 Jun 01; 89(6):393-406. PubMed ID: 35350025
    [Abstract] [Full Text] [Related]

  • 12. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
    Solomon JP, Linkov I, Rosado A, Mullaney K, Rosen EY, Frosina D, Jungbluth AA, Zehir A, Benayed R, Drilon A, Hyman DM, Ladanyi M, Sireci AN, Hechtman JF.
    Mod Pathol; 2020 Jan 01; 33(1):38-46. PubMed ID: 31375766
    [Abstract] [Full Text] [Related]

  • 13. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
    Marchiò C, Scaltriti M, Ladanyi M, Iafrate AJ, Bibeau F, Dietel M, Hechtman JF, Troiani T, López-Rios F, Douillard JY, Andrè F, Reis-Filho JS.
    Ann Oncol; 2019 Sep 01; 30(9):1417-1427. PubMed ID: 31268127
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and detection methodology for preliminary exploration of NTRK fusion in gastric cancer from a single-center retrospective cohort.
    Dong K, Yin L, Wang Y, Jia L, Diao X, Huang X, Zhou L, Lin D, Sun Y.
    Hum Pathol; 2024 Jun 01; 148():87-92. PubMed ID: 38653403
    [Abstract] [Full Text] [Related]

  • 15. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
    Csanyi-Bastien M, Lanic MD, Beaussire L, Ferric S, François A, Meseure D, Jardin F, Wassef M, Ruminy P, Laé M.
    Am J Surg Pathol; 2021 Nov 01; 45(11):1487-1498. PubMed ID: 33899788
    [Abstract] [Full Text] [Related]

  • 16. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
    Wu S, Liu Y, Shi X, Zhou W, Zeng X.
    Dig Liver Dis; 2023 Dec 01; 55(12):1757-1764. PubMed ID: 37142453
    [Abstract] [Full Text] [Related]

  • 17. Feasibility of two-step approach for screening NTRK fusion in two major subtypes of non-small cell lung cancer within a large cohort.
    Dong K, Zhu Y, Liu X, Sun W, Yang X, Chi K, Jia L, Diao X, Huang X, Zhou L, Lin D.
    Hum Pathol; 2024 Jul 01; 149():39-47. PubMed ID: 38866255
    [Abstract] [Full Text] [Related]

  • 18. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF.
    Endocr Pathol; 2020 Dec 01; 31(4):348-358. PubMed ID: 32880785
    [Abstract] [Full Text] [Related]

  • 19. NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS.
    Zito Marino F, Buono S, Montella M, Giannatiempo R, Messina F, Casaretta G, Arpino G, Vita G, Fiorentino F, Insabato L, Sgambato A, Orditura M, Franco R, Accardo M.
    J Pathol Clin Res; 2023 Sep 01; 9(5):367-377. PubMed ID: 37143440
    [Abstract] [Full Text] [Related]

  • 20. Detection of NTRK Fusions: Merits and Limitations of Current Diagnostic Platforms.
    Solomon JP, Hechtman JF.
    Cancer Res; 2019 Jul 01; 79(13):3163-3168. PubMed ID: 31196931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.